Brian Weinshenker, MD, Mayo Clinic, Rochester, MN, discusses the issues with the criteria to diagnose multiple sclerosis. Currently, the criteria are too liberal and can lead to the misdiagnosis of patients. This can have a major psychological impact on patients who are misdiagnosed. Therefore, there is a need for a new set of criteria for general use in the clinic. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.
Brian Weinshenker receives royalties from RSR Ltd, Oxford University, Hospices Civil de Lyon, and MVZ Labor PD Dr. Volkmann und Kollegen GbR for a patent of NMO-IgG as a diagnostic test for neuromyelitis optica spectrum disorders, served on adjudication committee for clinical trials in neuromyelitis optica spectrum disorders being conducted by MedImmune/VielaBio and Alexion, and consulted for Chugai/Roche/Genentech and Mitsubishi-Tanabe regarding a clinical trial for neuromyelitis optica spectrum disorders. He has received honoraria for speaking at internal meetings of Genentech, Novartis, and external meetings for Roche.